STOCK TITAN

Rhythm Pharmaceuticals director proposes $3.58M sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Rhythm Pharmaceuticals, Inc. director Lynn Tetrault reported a proposed sale of 37,000 common shares, with an aggregate market value of $3,581,230 and an approximate sale date of June 22, 2026. Tetrault acquired the shares from the issuer on June 22, 2026, through exercise of stock options with cash payment. The notice lists December 15, 2025, in the field for the plan adoption or instruction date if relying on Rule 10b5-1.

Shares proposed for sale 37,000 shares Common shares; approximate sale date June 22, 2026
Aggregate market value $3,581,230 Shares proposed for sale
Shares outstanding 68,532,607 shares Number of shares outstanding reported in the notice
Rule 10b5-1 regulatory
"Date of Plan Adoption or Giving of Instruction"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Exercise of Stock Options financial
"Nature of Acquisition Transaction"
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RYTM shares does director Lynn Tetrault propose to sell?

Lynn Tetrault, a director of Rhythm Pharmaceuticals, Inc., reported a proposed sale of 37,000 common shares, with an aggregate market value of $3,581,230 and an approximate sale date of June 22, 2026.

How did Lynn Tetrault acquire the RYTM shares in the notice?

Tetrault acquired the 37,000 shares from the issuer on June 22, 2026, through exercise of stock options, with cash payment. The notice lists December 15, 2025, as the plan adoption or instruction date in the field for reliance on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading